Latest News

GeoVax Awarded NIH Grant for Zika Vaccine
Supports Advanced Preclinical Testing in Preparation for Human Clinical Trials GeoVax Labs, Inc. (O...
Continue Reading...
GeoVax to Conduct Partnering Meetings During BIO International Convention June 19-22
GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human vaccines, announced today ...
Continue Reading...
GeoVax Presents Data on Novel Zika Vaccine
Unique Vaccine Based on Zika NS1 Protein Achieved 100% Protection in Lethal Challenge Model with a S...
Continue Reading...